MyFinsight
Home
Blog
About
Cash and cash
equivalents
$205,875K
(-31.49%↓ Y/Y)
Inventories, net
$134,575K
(-9.17%↓ Y/Y)
Accounts receivable, net
$132,420K
(15.79%↑ Y/Y)
Assets held for sale
$67,337K
Short-term
available-for-sale investments
$45,156K
(-68.94%↓ Y/Y)
Prepaid expenses and
other current assets
$29,852K
(-19.79%↓ Y/Y)
Total current assets
$615,215K
(-17.49%↓ Y/Y)
Intangible assets, net
$285,484K
(-32.44%↓ Y/Y)
Fixed assets, net
$130,277K
(-16.05%↓ Y/Y)
Deferred tax assets
$124,598K
(-2.86%↓ Y/Y)
Right-of-use assets, net
$44,920K
(-3.46%↓ Y/Y)
Investments and other assets
$23,842K
(26.75%↑ Y/Y)
Goodwill
$19,642K
(-3.24%↓ Y/Y)
Total assets
$1,243,978K
(-19.08%↓ Y/Y)
Total liabilities and
stockholders equity
$1,243,978K
(-19.08%↓ Y/Y)
Total stockholders
equity
$671,976K
(-11.32%↓ Y/Y)
Total liabilities
$572,002K
(-26.62%↓ Y/Y)
Treasury stock, at cost,
inclusive of excise tax and...
$227,013K
(200.62%↑ Y/Y)
Accumulated deficit
-$191,753K
(7.09%↑ Y/Y)
Additional paid-in capital
$1,087,452K
(5.01%↑ Y/Y)
Long-term debt, net
$363,124K
(271.19%↑ Y/Y)
Total current
liabilities
$122,011K
(-61.04%↓ Y/Y)
Lease liabilities
$38,695K
(-6.29%↓ Y/Y)
Other liabilities
$26,650K
(5.95%↑ Y/Y)
Contingent consideration
$17,452K
(1.41%↑ Y/Y)
Deferred tax liabilities
$4,070K
(-11.19%↓ Y/Y)
Accumulated other
comprehensive income
$3,241K
(-20.21%↓ Y/Y)
Common stock, par value
0.001 250,000,000...
$49K
(2.08%↑ Y/Y)
Accrued expenses
$93,499K
(31.65%↑ Y/Y)
Accounts payable
$17,509K
(-41.88%↓ Y/Y)
Lease liabilities
$10,298K
(7.05%↑ Y/Y)
Liabilities held for sale
$705K
Back
Back
Balance Sheet
Pacira BioSciences, Inc. (PCRX)
Pacira BioSciences, Inc. (PCRX)
source: myfinsight.com